Search

Search Constraints

You searched for: Author/Creator Venalis Algirdas author non-byline.

Search Results

1. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Issue 1 (23rd October 2014)

2. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Issue 7 (9th April 2019)

3. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Issue 7 (9th July 2019)

4. Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis. Issue 10 (25th March 2016)

5. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database. Issue 6 (30th June 2014)

6. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Issue 9 (21st June 2019)

7. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Issue 9 (21st September 2019)

8. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Issue 5 (11th May 2019)

9. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Issue 5 (9th March 2019)